title: Optimal management of cytomegalovirus retinitis in patients with AIDS.
abstract: Cytomegalovirus (CMV) retinitis is the most common cause of vision loss in patients with acquired immunodeficiency syndrome (AIDS). CMV retinitis afflicted 25% to 42% of AIDS patients in the pre-highly active antiretroviral therapy (HAART) era, with most vision loss due to macula-involving retinitis or retinal detachment. The introduction of HAART significantly decreased the incidence and severity of CMV retinitis. Optimal treatment of CMV retinitis requires a thorough evaluation of the patient's immune status and an accurate classification of the retinal lesions. When retinitis is diagnosed, HAART therapy should be started or improved, and anti-CMV therapy with oral valganciclovir, intravenous ganciclovir, foscarnet, or cidofovir should be administered. Selected patients, especially those with zone 1 retinitis, may receive intravitreal drug injections or surgical implantation of a sustained-release ganciclovir reservoir. Effective anti-CMV therapy coupled with HAART significantly decreases the incidence of vision loss and improves patient survival. Immune recovery uveitis and retinal detachments are important causes of moderate to severe loss of vision. Compared with the early years of the AIDS epidemic, the treatment emphasis in the post- HAART era has changed from short-term control of retinitis to long-term preservation of vision. Developing countries face shortages of health care professionals and inadequate supplies of anti-CMV and anti-HIV medications. Intravitreal ganciclovir injections may be the most cost effective strategy to treat CMV retinitis in these areas.
authors.affiliation: Department of Ophthalmology, Mayo School of Medicine, Jacksonville, FL, USA. stewart.michael@mayo.edu
authors.forename: Michael W
authors.initials: MW
authors.lastname: Stewart
references.citation: Drugs. 1998 Jul;56(1):115-46
references.pmid: 9664203
references.citation: J Clin Virol. 2002 Feb;24(1-2):67-77
references.pmid: 11744430
references.citation: Herpes. 2004 Dec;11(3):77-86
references.pmid: 15960905
references.citation: N Engl J Med. 1997 Jul 10;337(2):83-90
references.pmid: 9211677
references.citation: Ophthalmology. 2000 May;107(5):877-81; discussion 881-3
references.pmid: 10811078
references.citation: Retina. 2006 Feb;26(2):165-9
references.pmid: 16467672
references.citation: Am J Ophthalmol. 2007 Feb;143(2):334-5
references.pmid: 17258523
references.citation: J Clin Pharmacol. 1999 Aug;39(8):800-4
references.pmid: 10434231
references.citation: Clin Exp Ophthalmol. 2005 Jun;33(3):317-29
references.pmid: 15932540
references.citation: Am J Ophthalmol. 2007 Nov;144(5):781-5
references.pmid: 17707328
references.citation: J Infect Dis. 2005 Aug 15;192(4):640-9
references.pmid: 16028133
references.citation: Am J Ophthalmol. 2005 Nov;140(5):900-2
references.pmid: 16310469
references.citation: Am J Ophthalmol. 1982 Apr;93(4):393-402
references.pmid: 6280503
references.citation: Int Ophthalmol Clin. 2004 Summer;44(3):33-9
references.pmid: 15211175
references.citation: J Infect Dis. 1995 Oct;172(4):951-6
references.pmid: 7561215
references.citation: N Engl J Med. 1981 Dec 10;305(24):1431-8
references.pmid: 6975437
references.citation: Ethiop Med J. 2007 Oct;45(4):327-34
references.pmid: 18326342
references.citation: Br J Ophthalmol. 2009 Jan;93(1):88-90
references.pmid: 18952644
references.citation: Br J Ophthalmol. 1999 May;83(5):540-5
references.pmid: 10216051
references.citation: J Infect Dis. 2001 Dec 15;184(12):1598-602
references.pmid: 11740736
references.citation: Am J Ophthalmol. 1997 Aug;124(2):141-57
references.pmid: 9262538
references.citation: Clin Infect Dis. 2007 Apr 1;44(7):1001-8
references.pmid: 17342657
references.citation: Ocul Immunol Inflamm. 1999 Dec;7(3-4):173-7
references.pmid: 10611725
references.citation: Clin Infect Dis. 1996 Apr;22 Suppl 1:S43-7; discussion S47-9
references.pmid: 8785256
references.citation: Am J Public Health. 1993 Oct;83(10):1385-9
references.pmid: 8214225
references.citation: Drug Saf. 1999 Sep;21(3):203-24
references.pmid: 10487398
references.citation: Antiviral Res. 2006 Sep;71(2-3):154-63
references.pmid: 16765457
references.citation: J Infect Dis. 1993 Dec;168(6):1506-9
references.pmid: 8245536
references.citation: HIV Clin Trials. 2005 May-Jun;6(3):136-46
references.pmid: 16192248
references.citation: Lancet Infect Dis. 2006 Aug;6(8):461-2
references.pmid: 16870523
references.citation: Ophthalmology. 2004 Dec;111(12):2232-9
references.pmid: 15582079
references.citation: Ann Intern Med. 1988 Dec 15;109(12):963-9
references.pmid: 2848436
references.citation: Am J Ophthalmol. 2003 Jan;135(1):26-34
references.pmid: 12504693
references.citation: J Clin Virol. 2004 Jun;30(2):115-33
references.pmid: 15125867
references.citation: Am J Ophthalmol. 1993 May 15;115(5):575-82
references.pmid: 8098183
references.citation: Am J Ophthalmol. 2008 Jan;145(1):12-22
references.pmid: 18154751
references.citation: MMWR Recomm Rep. 2004 Dec 17;53(RR-15):1-112
references.pmid: 15841069
references.citation: Clin Infect Dis. 2006 Nov 1;43(9):1143-51
references.pmid: 17029132
references.citation: N Engl J Med. 1981 Dec 10;305(24):1425-31
references.pmid: 6272109
references.citation: N Engl J Med. 2002 Apr 11;346(15):1119-26
references.pmid: 11948271
references.citation: J Indian Med Assoc. 2008 May;106(5):292-4
references.pmid: 18839634
references.citation: Drugs. 1999 Aug;58(2):325-45
references.pmid: 10473024
references.citation: Niger Postgrad Med J. 2008 Mar;15(1):24-7
references.pmid: 18408779
references.citation: J Microbiol Immunol Infect. 2000 Mar;33(1):45-8
references.pmid: 10806964
references.citation: Am J Ophthalmol. 2005 Jun;139(6):1028-34
references.pmid: 15953432
references.citation: J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):972-7
references.pmid: 15220705
references.citation: Clin Infect Dis. 2003 Nov 15;37(10):1365-73
references.pmid: 14583871
references.citation: Retina. 1999;19(4):274-80
references.pmid: 10458290
references.citation: Pharmacoeconomics. 2007;25(5):413-28
references.pmid: 17488139
references.citation: Am J Ophthalmol. 2002 Jan;133(1):48-61
references.pmid: 11755839
references.citation: Ophthalmology. 2004 Dec;111(12):2224-31
references.pmid: 15582078
references.citation: Ophthalmology. 1996 Jul;103(7):1078-83
references.pmid: 8684797
references.citation: Ophthalmology. 2006 Apr;113(4):684-94
references.pmid: 16581429
references.citation: J Infect Dis. 1998 Mar;177(3):770-3
references.pmid: 9498461
references.citation: Curr Opin Ophthalmol. 2007 Nov;18(6):487-92
references.pmid: 18163001
references.citation: J Med Assoc Thai. 2005 Jan;88(1):103-7
references.pmid: 15960227
references.citation: Trans Am Ophthalmol Soc. 1995;93:623-83
references.pmid: 8719695
references.citation: J Infect Dis. 2003 Mar 1;187(5):777-84
references.pmid: 12599051
references.citation: N Engl J Med. 1996 Aug 8;335(6):377-83
references.pmid: 8676931
references.citation: Br J Ophthalmol. 1994 Feb;78(2):120-4
references.pmid: 8123619
references.citation: J Infect. 2007 Nov;55(5):464-9
references.pmid: 17714788
references.citation: Am J Ophthalmol. 1992 Dec 15;114(6):742-7
references.pmid: 1334376
references.citation: Am J Ophthalmol. 2001 Apr;131(4):457-67
references.pmid: 11292409
references.citation: Herpes. 2007 Dec;14(3):66-71
references.pmid: 18371289
references.citation: Arch Ophthalmol. 1996 Jan;114(1):23-33
references.pmid: 8540847
references.citation: J Acquir Immune Defic Syndr (1988). 1992;5(11):1069-74
references.pmid: 1357151
references.citation: Curr HIV/AIDS Rep. 2008 Aug;5(3):120-5
references.pmid: 18627660
references.citation: Br J Ophthalmol. 1999 Mar;83(3):339-42
references.pmid: 10365044
references.citation: Antimicrob Agents Chemother. 1998 Sep;42(9):2240-4
references.pmid: 9736542
references.citation: N Engl J Med. 1995 Sep 7;333(10):615-20
references.pmid: 7637721
references.citation: Retina. 2004 Jun;24(3):376-82
references.pmid: 15187659
references.citation: Drugs. 1990 Apr;39(4):597-638
references.pmid: 2161731
references.citation: Arch Ophthalmol. 1989 Dec;107(12):1759-66
references.pmid: 2556989
references.citation: Ophthalmology. 2007 Feb;114(2):334-9
references.pmid: 17270681
references.citation: AIDS Res Ther. 2007 May 08;4:9
references.pmid: 17488505
references.citation: Lancet. 2006 Mar 11;367(9513):817-24
references.pmid: 16530575
references.citation: Retina. 2001;21(1):1-9
references.pmid: 11217922
references.citation: Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):264-71
references.pmid: 18780260
references.citation: N Engl J Med. 1994 Mar 24;330(12):868-9
references.pmid: 8114855
references.citation: Pharmacoeconomics. 2001;19(12):1199-208
references.pmid: 11772155
references.citation: N Engl J Med. 1999 Apr 8;340(14):1063-70
references.pmid: 10194235
references.citation: Am J Ophthalmol. 2000 Jan;129(1):9-15
references.pmid: 10653406
references.citation: Am J Ophthalmol. 1987 Jan 15;103(1):17-23
references.pmid: 3026186
references.citation: Am J Ophthalmol. 2008 Mar;145(3):397-408
references.pmid: 18282490
references.citation: J Infect Dis. 1981 Feb;143(2):188-92
references.pmid: 6260871
references.citation: Ophthalmology. 2007 Apr;114(4):787-93
references.pmid: 17210182
references.citation: Clin Infect Dis. 2004 Apr 15;38(8):1159-66
references.pmid: 15095223
references.citation: Clin Pharmacokinet. 1999 Aug;37(2):167-76
references.pmid: 10496303
references.citation: Am J Med Sci. 1999 May;317(5):318-35
references.pmid: 10334120
references.citation: AIDS. 2005 Apr 29;19(7):735-8
references.pmid: 15821403
references.citation: Ophthalmology. 2007 Apr;114(4):780-6
references.pmid: 17258320
references.citation: J Infect Dis. 1999 Mar;179(3):697-700
references.pmid: 9952380
references.citation: Drugs. 1994 Sep;48(3):455-84
references.pmid: 7527763
references.citation: Ophthalmology. 1991 Sep;98(9):1348-53; discussion 1353-5
references.pmid: 1658703
references.citation: Arch Ophthalmol. 2008 Aug;126(8):1143-6
references.pmid: 18695113
references.citation: N Engl J Med. 1997 Jul 10;337(2):105-14
references.pmid: 9211681
references.citation: Ophthalmology. 2006 Aug;113(8):1432-40
references.pmid: 16766032
references.citation: Niger J Clin Pract. 2007 Dec;10(4):283-6
references.pmid: 18293635
references.citation: Ophthalmology. 2005 May;112(5):771-9
references.pmid: 15878056
references.citation: Med J Aust. 1992 Sep 21;157(6):370-3
references.pmid: 1333036
references.citation: Drugs. 2005;65(6):859-78
references.pmid: 15819597
references.citation: HIV Clin Trials. 2006 Jan-Feb;7(1):1-9
references.pmid: 16632459
references.citation: J Infect Dis. 1992 Dec;166(6):1223-7
references.pmid: 1358986